{"id":"https://openalex.org/W7171963283","doi":"https://doi.org/10.1192/j.eurpsy.2026.10499","title":"Population Pharmacogenetic-Pharmacokinetic Approach in the Context of Methadone Administration in Galicia, Spain","display_name":"Population Pharmacogenetic-Pharmacokinetic Approach in the Context of Methadone Administration in Galicia, Spain","publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7171963283","doi":"https://doi.org/10.1192/j.eurpsy.2026.10499","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13441749"},"language":"en","primary_location":{"id":"doi:10.1192/j.eurpsy.2026.10499","doi":"https://doi.org/10.1192/j.eurpsy.2026.10499","is_oa":true,"landing_page_url":"https://doi.org/10.1192/j.eurpsy.2026.10499","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6ADD78D5E75AC4128D5781030EB19EE1/S0924933826104994a.pdf/div-class-title-population-pharmacogenetic-pharmacokinetic-approach-in-the-context-of-methadone-administration-in-galicia-spain-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6ADD78D5E75AC4128D5781030EB19EE1/S0924933826104994a.pdf/div-class-title-population-pharmacogenetic-pharmacokinetic-approach-in-the-context-of-methadone-administration-in-galicia-spain-div.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037400264","display_name":"Jes\u00fas G\u00f3mez-Trigo","orcid":"https://orcid.org/0000-0003-3221-4196","observed_orcids":["https://orcid.org/0000-0003-3221-4196"]},"institutions":[{"id":"https://openalex.org/I4210096311","display_name":"Complejo Hospitalario Universitario de Santiago","ror":"https://ror.org/00mpdg388","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096311"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"J. Gomez-Trigo","raw_affiliation_strings":["Servicio de Psiquiatr\u00eda, Complejo Hospitalario Universitario de Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Psiquiatr\u00eda, Complejo Hospitalario Universitario de Santiago de Compostela","institution_ids":["https://openalex.org/I4210096311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116381657","display_name":"Sheila Recarey-Rama","orcid":"https://orcid.org/0009-0003-1623-1110","observed_orcids":["https://orcid.org/0009-0003-1623-1110"]},"institutions":[{"id":"https://openalex.org/I4210148771","display_name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago","ror":"https://ror.org/05n7xcf53","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210148771"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"S. Recarey-Rama","raw_affiliation_strings":["Grupo de Farmacogen\u00f3mica y Descubrimiento de Medicamentos, Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Farmacogen\u00f3mica y Descubrimiento de Medicamentos, Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS","institution_ids":["https://openalex.org/I4210148771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144120843","display_name":"A. Gil Rodr\u00edguez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148771","display_name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago","ror":"https://ror.org/05n7xcf53","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210148771"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Gil Rodr\u00edguez","raw_affiliation_strings":["Grupo de Farmacogen\u00f3mica y Descubrimiento de Medicamentos, Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Farmacogen\u00f3mica y Descubrimiento de Medicamentos, Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS","institution_ids":["https://openalex.org/I4210148771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5116838666","display_name":"Ana Rodr\u00edguez-Viyuela","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111807","display_name":"Center for Research in Molecular Medicine and Chronic Diseases","ror":"https://ror.org/0280bnq76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111807"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Rodr\u00edguez-Viyuela","raw_affiliation_strings":["Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela","institution_ids":["https://openalex.org/I4210111807"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144126023","display_name":"R. Cruz-Guerrero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111807","display_name":"Center for Research in Molecular Medicine and Chronic Diseases","ror":"https://ror.org/0280bnq76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111807"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R. Cruz-Guerrero","raw_affiliation_strings":["Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela","institution_ids":["https://openalex.org/I4210111807"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117314399","display_name":"Alba Barral-Ra\u00f1a","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148771","display_name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago","ror":"https://ror.org/05n7xcf53","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210148771"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. M. Barral-Ra\u00f1a","raw_affiliation_strings":["Grupo de Farmacogen\u00f3mica y Descubrimiento de Medicamentos, Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Farmacogen\u00f3mica y Descubrimiento de Medicamentos, Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela (IDIS","institution_ids":["https://openalex.org/I4210148771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144092174","display_name":"E. Dom\u00ednguez-Medina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111807","display_name":"Center for Research in Molecular Medicine and Chronic Diseases","ror":"https://ror.org/0280bnq76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111807"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Dom\u00ednguez-Medina","raw_affiliation_strings":["Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela","institution_ids":["https://openalex.org/I4210111807"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136195320","display_name":"Manuel Arrojo Romero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096311","display_name":"Complejo Hospitalario Universitario de Santiago","ror":"https://ror.org/00mpdg388","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096311"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. Arrojo-Romero","raw_affiliation_strings":["Servicio de Psiquiatr\u00eda, Complejo Hospitalario Universitario de Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Psiquiatr\u00eda, Complejo Hospitalario Universitario de Santiago de Compostela","institution_ids":["https://openalex.org/I4210096311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5144102918","display_name":"O. Maro\u00f1as-Amigo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111807","display_name":"Center for Research in Molecular Medicine and Chronic Diseases","ror":"https://ror.org/0280bnq76","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210111807"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"O. Maro\u00f1as-Amigo","raw_affiliation_strings":["Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo de Medicina Gen\u00f3mica, Centro de Investigaci\u00f3n en Medicina Molecular y Enfermedades Cr\u00f3nicas (CiMUS), Santiago de Compostela","institution_ids":["https://openalex.org/I4210111807"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5037400264"],"corresponding_institution_ids":["https://openalex.org/I4210096311"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":{"value":3300,"currency":"USD","value_usd":3300},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"S1","first_page":"S192","last_page":"S192"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methadone","display_name":"methadone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.9129999876022339},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.984000027179718},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9520000219345093},{"id":"https://openalex.org/keywords/cyp2b6","display_name":"CYP2B6","score":0.9589999914169312},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9990000128746033},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.718999981880188},{"id":"https://openalex.org/keywords/methadone-substitution-therapy","display_name":"methadone substitution","score":0.9049999713897705},{"id":"https://openalex.org/keywords/metabolizer-phenotypes","display_name":"metabolizer phenotypes","score":0.7369999885559082},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.8410000205039978},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.722000002861023},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.8009999990463257},{"id":"https://openalex.org/keywords/galicia","display_name":"Galicia","score":0.8600000143051147}],"concepts":[{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.8967000246047974},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.6261000037193298},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5961999893188477},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5911999940872192},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5602999925613403},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.5497000217437744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5163999795913696},{"id":"https://openalex.org/C50605568","wikidata":"https://www.wikidata.org/wiki/Q14912267","display_name":"CYP2B6","level":5,"score":0.5056999921798706},{"id":"https://openalex.org/C31467283","wikidata":"https://www.wikidata.org/wiki/Q912147","display_name":"Genotyping","level":4,"score":0.4948999881744385},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49160000681877136},{"id":"https://openalex.org/C2909451232","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opiate Substitution Treatment","level":5,"score":0.4275999963283539},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4120999872684479},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.41200000047683716},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4034999907016754},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3763999938964844},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.36559998989105225},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.3646000027656555},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.35690000653266907},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.32249999046325684},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3102000057697296},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.2865000069141388},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.28519999980926514},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.27230000495910645},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.2703999876976013},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.26570001244544983},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.26080000400543213},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.257999986410141},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.25699999928474426},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.25189998745918274},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.2513999938964844}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1192/j.eurpsy.2026.10499","doi":"https://doi.org/10.1192/j.eurpsy.2026.10499","is_oa":true,"landing_page_url":"https://doi.org/10.1192/j.eurpsy.2026.10499","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6ADD78D5E75AC4128D5781030EB19EE1/S0924933826104994a.pdf/div-class-title-population-pharmacogenetic-pharmacokinetic-approach-in-the-context-of-methadone-administration-in-galicia-spain-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13441749","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13441749/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur Psychiatry","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1192/j.eurpsy.2026.10499","doi":"https://doi.org/10.1192/j.eurpsy.2026.10499","is_oa":true,"landing_page_url":"https://doi.org/10.1192/j.eurpsy.2026.10499","pdf_url":"https://www.cambridge.org/core/services/aop-cambridge-core/content/view/6ADD78D5E75AC4128D5781030EB19EE1/S0924933826104994a.pdf/div-class-title-population-pharmacogenetic-pharmacokinetic-approach-in-the-context-of-methadone-administration-in-galicia-spain-div.pdf","source":{"id":"https://openalex.org/S87202501","display_name":"European Psychiatry","issn_l":"0924-9338","issn":["0924-9338","1778-3585"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Psychiatry","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7171963283.pdf","grobid_xml":"https://content.openalex.org/works/W7171963283.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2183254285","https://openalex.org/W2152506996","https://openalex.org/W2758889194","https://openalex.org/W2793264615","https://openalex.org/W2151827878","https://openalex.org/W7033226181","https://openalex.org/W4390055879","https://openalex.org/W3016390381","https://openalex.org/W6920502195","https://openalex.org/W2624790165"],"abstract_inverted_index":{"Introduction":[0],"Methadone":[1],"is":[2,27,212],"a":[3,69,130],"synthetic":[4],"opioid":[5,256],"with":[6],"slow-onset":[7],"activity,":[8],"acting":[9],"as":[10,18],"an":[11,19],"agonist":[12],"at":[13,21],"\u03bc-opioid":[14],"receptors":[15],"(MOR)":[16],"and":[17,38,59,76,104,111,128,163,176,185,225,238],"antagonist":[20],"N-methyl-D-aspartate":[22],"(NMDA)":[23],"receptors.":[24],"Its":[25],"biotransformation":[26],"primarily":[28],"mediated":[29],"by":[30,89,209],"cytochrome":[31],"P450":[32],"enzymes,":[33,162,201],"including":[34,107],"CYP3A4,":[35],"CYP2C19,":[36],"CYP2D6,":[37],"particularly":[39],"CYP2B6,":[40],"which":[41],"exhibits":[42],"preferential":[43],"metabolism":[44,224],"of":[45,114,132,170,253,260],"the":[46,98,115,141,155,159,199,203,206,213,231,243,251],"R-enantiomer.":[47],"Single":[48],"nucleotide":[49],"polymorphisms":[50],"(SNPs)":[51],"have":[52],"been":[53,81],"shown":[54],"to":[55,61,65,96,153,165],"influence":[56],"methadone":[57,102,120,137,171,223,240,254],"pharmacokinetics":[58],"contribute":[60],"interindividual":[62],"variability.":[63],"Owing":[64],"this":[66,210],"metabolic":[67],"variability,":[68],"consistent":[70],"correlation":[71,219],"between":[72,100,183,222,234],"dose,":[73],"plasma":[74,101,167,239],"concentration,":[75],"clinical":[77,90],"effect":[78],"has":[79],"not":[80],"established,":[82],"thereby":[83],"necessitating":[84],"individualized":[85],"dose":[86],"titration":[87],"guided":[88],"response.":[91],"Objectives":[92],"This":[93,123],"study":[94,125],"aims":[95],"elucidate":[97],"relationship":[99],"concentrations":[103,241],"patient-specific":[105],"variables,":[106],"body":[108,227],"weight,":[109,228],"sex,":[110,230],"metabolizer":[112,156,236],"phenotypes":[113],"principal":[116],"genes":[117],"implicated":[118],"in":[119,136,140,249],"biotransformation.":[121],"Methods":[122],"descriptive":[124],"involved":[126],"genotyping":[127],"phenotyping":[129],"cohort":[131],"80":[133],"patients":[134],"enrolled":[135],"substitution":[138],"programs":[139],"Galician":[142],"community.":[143],"Two":[144],"blood":[145],"samples":[146],"were":[147,181,196],"collected":[148],"from":[149],"each":[150],"participant:":[151],"one":[152],"determine":[154],"phenotype":[157],"for":[158,168,198,245,255],"previously":[160],"mentioned":[161],"another":[164],"isolate":[166],"quantification":[169],"concentrations.":[172],"Results":[173],"Following":[174],"pharmacogenetic":[175],"pharmacokinetic":[177],"analyses,":[178],"significant":[179,194],"differences":[180],"observed":[182,232],"normal":[184],"intermediate":[186],"CYP3A4":[187,235],"metabolizers":[188],"(p":[189],"=":[190],"0.0327),":[191],"whereas":[192],"no":[193,218],"associations":[195],"found":[197],"other":[200],"supporting":[202],"hypothesis":[204],"that":[205],"enzyme":[207],"encoded":[208],"gene":[211],"predominant":[214],"contributor.":[215],"Conclusions":[216],"Although":[217],"was":[220],"detected":[221],"BMI,":[226],"or":[229],"association":[233],"status":[237],"highlights":[242],"potential":[244],"precision":[246],"medicine":[247],"approaches":[248],"guiding":[250],"prescription":[252],"use":[257],"disorder.":[258],"Disclosure":[259],"Interest":[261],"None":[262],"Declared":[263]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-08-01T00:00:00"}